Skip to main content
Equasens logo

Equasens — Investor Relations & Filings

Ticker · EQS ISIN · FR0012882389 LEI · 96950066I7XVFGZI8L92 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2018-05-16 Earnings Release
Country FR France
Listing PA EQS

About Equasens

https://equasens.com

Equasens is a company specializing in healthcare IT solutions for professionals and establishments. It develops and provides a range of products including professional software, electronic equipment, connected devices, and digital health solutions. The company's offerings cater to a diverse client base, including pharmacies, hospitals, nursing homes (EHPADs), home care services, and independent medical practitioners. The primary objective of its solutions is to improve the quality of patient care by facilitating the secure sharing of health data, enhancing communication between different care providers, and optimizing the coordination of care pathways across outpatient, hospital, and home care settings.

Recent filings

Filing Released Lang Actions
PHARMAGEST INTERACTIVE : Chiffre d'affaires du 1er trimestre 2018
Earnings Release Classification · 1% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and focuses entirely on announcing the 'Chiffre d'affaires du 1er trimestre 2018' (First Quarter 2018 Revenue). It provides key financial figures (revenue progression, divisional breakdown) and outlook, which is characteristic of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial, high-level announcement of period results. The document also mentions the upcoming Annual General Meeting (AGM) date, but the primary content is the quarterly financial performance announcement. Q1 2018
2018-05-16 French
PHARMAGEST INTERACTIVE : Document de référence disponible
Report Publication Announcement Classification · 1% confidence The document is a press release dated May 2, 2018, titled "Mise à disposition du Document de Référence 2017" (Making available of the 2017 Reference Document). It explicitly states that the 2017 Reference Document (Document de Référence 2017) has been filed with the AMF (Autorité des Marchés Financiers) and is available online. The text details that this Reference Document incorporates the 2017 annual financial report, the corporate governance report, and the share repurchase program description. Since the document's primary function is to announce that a major regulatory report (the Reference Document, which contains the annual report components) has been published and is available for consultation elsewhere, it fits the definition of a Report Publication Announcement (RPA). The document length (3378 chars) is short, supporting the 'announcement' classification over the full report (10-K or AR).
2018-05-02 French
PHARMAGEST: enters Italy with the acquisition of market l
M&A Activity Classification · 1% confidence The document announces a significant corporate action: the acquisition of a majority stake in an Italian company (MACROSOFT) by PHARMAGEST Group, leading to the creation of a new subsidiary, Pharmagest Italia. This type of strategic business development, involving mergers, acquisitions, or major structural changes, falls under the category of M&A Activity (TAR). Although it contains financial figures (€5.2 million sales), the primary focus is the transaction itself, not a periodic financial report (like 10-K or IR) or an earnings release (ER). It is not a management change (MANG) or a capital raising event (CAP), but a transaction to expand market presence.
2018-03-09 English
PHARMAGEST INTERACTIVE : croissance externe en Italie
Earnings Release Classification · 1% confidence The document is a press release dated March 8, 2018, announcing that Groupe Pharmagest is expanding into Italy through the majority acquisition (60%) of MACROSOFT Holding, a leader in IT equipment and services for pharmaceutical wholesalers in Italy. This announcement details a significant corporate transaction (M&A activity) and the subsequent creation of a new subsidiary, Pharmagest Italia. While it mentions a future financial event (publication of 2017 annual results on April 3, 2018), the primary content is the acquisition itself. This fits best under the M&A Activity category (TAR). It is not a full 10-K, an earnings release (ER), or a general regulatory filing (RNS), as the subject is clearly defined as a takeover/acquisition proposal. FY 2018
2018-03-08 French
Pharmagest - bilan annuel du contrat de liquidité -2017
Capital/Financing Update Classification · 1% confidence The document is a press release dated February 16, 2018, titled "BILAN ANNUEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT" (Annual Report of the Liquidity Contract with Gilbert Dupont Stock Brokerage Firm). It details the status (number of shares and cash balance) of a liquidity contract as of December 29, 2017, and compares it to the previous semi-annual balance from June 30, 2017. This type of regular disclosure regarding market making or liquidity arrangements, often mandated by stock exchanges or regulatory bodies, does not fit neatly into the primary financial reporting categories (10-K, IR, ER). It is a specific regulatory or contractual disclosure. Given the options, it is a specific announcement that is not a dividend, director dealing, capital change, or earnings release. It is most appropriately classified as a general Regulatory Filing (RNS) as it is a specific, non-standard disclosure required by market rules, or potentially a Transaction in Own Shares (POS) if the liquidity contract is viewed as managing treasury stock, but RNS is a safer fallback for specific contractual updates not covered elsewhere. Since it is a formal, periodic update on a specific financial arrangement (liquidity contract), and not a general press release about business operations or results, RNS is the best fit among the provided codes for a miscellaneous regulatory disclosure.
2018-02-16 French
PHARMAGEST INTERACTIVE presents its AI solutions for Seniors at the
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces the launch of new connected care solutions (NoviaCare and CareLib) at CES 2018, including pricing and availability dates (June 2018). This is a general announcement regarding a new product/service offering and strategic direction, rather than a formal regulatory filing like a 10-K, an earnings report (ER), or a specific capital event. It functions as a corporate news announcement. Since there is no specific category for 'Product Launch Announcement' or 'General Corporate News', the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that don't fit the highly specific financial report types.
2018-01-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.